首页
产品目录
分子砌块
按官能团
酰胺类
(R)-N-((4-甲氧基-6-甲基-2-氧代-1,2-二氢吡啶-3-基)甲基)-2-甲基-1-(1-(1-(2,2,2-三氟乙基)哌啶-4-基)乙基)-1H-吲哚-3-甲酰胺
(R)-N-((4-甲氧基-6-甲基-2-氧代-1,2-二氢吡啶-3-基)甲基)-2-甲基-1-(1-(1-(2,2,2-三氟乙基)哌啶-4-基)乙基)-1H-吲哚-3-甲酰胺
(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide
产品编号 :
ACJMVN813
Cas No. :
1621862-70-1
包装规格
纯度
目录价
会员专享价
库存
数量
抱歉,暂无牌价信息
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。
基础信息
CAS No.
1621862-70-1
中文名称
(R)-N-((4-甲氧基-6-甲基-2-氧代-1,2-二氢吡啶-3-基)甲基)-2-甲基-1-(1-(1-(2,2,2-三氟乙基)哌啶-4-基)乙基)-1H-吲哚-3-甲酰胺
英文名称
(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide
别名
DB14581 | AC-35895 | N-[(4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-2-methyl-1-[(1R)-1-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]ethyl]-1H-indole-3-carboxamide | A19399 | HPODOLXTMDHLLC-QGZVFWFLSA-N | 1450656-11-7 | 1621862-70-1 | CPI 1205 | L
标准英文名
(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide
MDL No.
MFCD30470657
分子式
C2 7 H3 3 F3 N4 O3
分子量
518.58
精确分子量
518.25
SMILES
COC1=C(CNC(=O)C2=C(C)N([C@H](C)C3CCN(CC(F)(F)F)CC3)C3=CC=CC=C23)C(=O)NC(C)=C1
标准SMILES
C[C@H](C1CCN(CC(F)(F)F)CC1)N1C2=CC=CC=C2C(C(=O)NCC2=C(C=C(C)NC2=O)OC)=C1C
用途
CPI-1205 (Lirametostat) is a selective, orally bioavailable inhibitor of the histone lysine methyltransferase EZH2, with potential antitumor activity; it induces apoptosis in multiple myeloma and plasmacytoma cell models.
InChIKey
HPODOLXTMDHLLC-QGZVFWFLSA-N
SureRoute逆合成路线
1. 1621862-70-1 逆合成路线 1
ACSVDA198
1438382-15-0
现货
2. 1621862-70-1 逆合成路线 2
ACSVDA198
1438382-15-0
现货